Effects of the NO-synthase Inhibitor VAS203 on Renal Function in Healthy Volunteers
Phase 1
Completed
- Conditions
- Renal Function Impairment in Healthy Volunteers
- Interventions
- Drug: SalineDrug: VAS203
- First Posted Date
- 2016-12-14
- Last Posted Date
- 2019-08-09
- Lead Sponsor
- veriNOS operations GmbH
- Target Recruit Count
- 16
- Registration Number
- NCT02992236
- Locations
- 🇩🇪
Universitätsklinik Erlangen, Erlangen, Germany
Efficacy of VAS203 (Ronopterin) in Patients With Moderate and Severe Traumatic Brain Injury
Phase 3
Completed
- Conditions
- Traumatic Brain Injury
- Interventions
- Drug: VAS203Drug: Saline
- First Posted Date
- 2016-06-08
- Last Posted Date
- 2021-10-11
- Lead Sponsor
- veriNOS operations GmbH
- Target Recruit Count
- 224
- Registration Number
- NCT02794168
- Locations
- 🇫🇷
Hôpital Pellegrin Service de réanimation traumatologique et chirurgicale, Bordeaux, France
🇫🇷Pôle Anesthésie Réanimation Douleur Urgence, Nimes, France
🇫🇷Hopital Gabriel Montpied, Clermont-Ferrand, France
Phase 2 a Study to Assess Safety and Pharmacokinetics of VAS203 in Patients With Traumatic Brain Injury
Phase 2
Completed
- Conditions
- Traumatic Brain Injury
- Interventions
- Drug: VAS203Drug: Saline
- First Posted Date
- 2013-12-16
- Last Posted Date
- 2016-03-07
- Lead Sponsor
- veriNOS operations GmbH
- Target Recruit Count
- 32
- Registration Number
- NCT02012582
- Locations
- 🇦🇹
Medical University Innsbruck Department of Neurology, Innsbruck, Austria
🇫🇷HIA Sainte-Anne Boulevard Sainte-Anne, Toulon, France
🇪🇸Vall d'Hebron University Hospital Department of Neurosurgery, Barcelona, Spain
© Copyright 2025. All Rights Reserved by MedPath